Smith & Nephew launches uterine fibroid device; DioGenix raises cash to study MS diagnostic;

 @FierceMedDev: Quidel wins 510(k) for C. difficile molecular Dx. More | Follow @FierceMedDev

@MarkHFierce: More Dx funding--this time for Ortho Kinematics, a spine imaging Dx company--$2M Series B. Item | Follow @MarkHFierce

 @DamianFierce: Medtronic posts more good renal denervation data, but it faces mounting competition from $BSX, $STJ. Story | Follow @DamianFierce

> A South Dakota hospital became only the fifth health system in the country to start using robots to assist with stent placement. Corindus Vascular Robotics developed this latest system. Story

> Smith & Nephew ($SNN) has launched the Truclear Ultra Reciprocating Morcellator, designed for the removal of uterine fibroids, which affect about 80% of women, the company says. News

> 2012 Fierce 15 winner T2 Biosystems snagged a patent for its T2MR platform, used in its T2Candida diagnostic that tests for 5 species of a leading hospital-acquired infection. More

> Many women who receive inconclusive BRCA tests choose risky and often unneeded ovarian cancer diagnostics, according to a new survey. Story

> Molecular diagnostics outfit DioGenix has raised $1.5 million to support a prospective, multi-site clinical trial to validate MSPrecise, a test for multiple sclerosis. Release

> Tyrx, a 2012 Fierce 15 medical device company, is reporting positive clinical trial results for its new AIGISRx antibacterial envelope, which is designed to reduce infection with pacemakers and implantable defibrillators. Item

> Clear Guide Medical, a Johns Hopkins spinoff, is developing a device used for minimally invasive ultrasound surgical device with an eye toward a 2014 commercial launch. Story

Biotech News

 @FierceBiotech: Celgene wraps $500M deal to partner with Sutro on next-gen ADCs. Article | Follow @FierceBiotech

@JohnCFierce: Hey, Actelion is (kind of) on a roll, with positive psoriasis data on PhII drug. Handily beats placebo. Article | Follow @JohnCFierce

@RyanMFierce: Interesting how Merck is using GE's experimental imaging agent in Alzheimer's trial for MK-8931. Does this add risk? Report | Follow @RyanMFierce

> Vanda shares soar on positive PhIII data. Item

> Troubled drug developer Enzon looks for buyer as Icahn asks for chat. News

> Langer biotech adds $16M in venture cash to back next-gen cancer drugs. Story

Pharma News

@FiercePharma: A blow to Roche's Avastin hopes as NICE rejects it for ovarian cancer. Article | Follow @FiercePharma

> Mylan chief jets to pop singer son's concerts on company aircraft. Story

> Amgen on verge of guilty plea in $780M settlement. News

Pharma Manufacturing News

> ICIG adds Tessenderlo plants to its portfolio. Report

> Teva puts brakes on $300M Philly warehouse. News

> FDA's counterfeit drug probe sweeps up cancer doc. Article

Biotech Research News

> Acetylon's HDAC drug fights sickle cell disease, beta thalassemia in blood cell studies. Item

> Lifting the mood: Antidepressant could double as diabetes drug. Report

> Engineered viruses rebuild heartbeat. Article

> Rejected diabetes drug wakes up cell memories in Alzheimer's. News

> Gene therapy flips switch in sickle cell disease. Story

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.